Literature DB >> 25819532

Supernatants from stored red blood cell (RBC) units, but not RBC-derived microvesicles, suppress monocyte function in vitro.

Jennifer A Muszynski1,2,3, Justin Bale2, Jyotsna Nateri2, Kathleen Nicol4, Yijie Wang3, Valerie Wright3, Clay B Marsh3, Mikhail A Gavrilin3, Anasuya Sarkar3, Mark D Wewers3, Mark W Hall1,2,3.   

Abstract

BACKGROUND: We have previously shown that critically ill children transfused with red blood cells (RBCs) of longer storage durations have more suppressed monocyte function after transfusion compared to children transfused with fresher RBCs and that older stored RBCs directly suppress monocyte function in vitro, through unknown mechanisms. We hypothesized that RBC-derived microvesicles (MVs) were responsible for monocyte suppression. STUDY DESIGN AND METHODS: To determine the role of stored RBC unit-derived MVs, we cocultured monocytes with supernatants, isolated MVs, or supernatants that had been depleted of MVs from prestorage leukoreduced RBCs that had been stored for either 7 or 30 days. Isolated MVs were characterized by electron microscopy and flow cytometry. Monocyte function after coculture experiments was measured by cytokine production after stimulation with lipopolysaccharide (LPS).
RESULTS: Monocyte function was suppressed after exposure to supernatants from 30-day RBC units compared to monocytes cultured in medium alone (LPS-induced tumor necrosis factor-α production, 17,611 ± 3,426 vs. 37,486 ± 5,598 pg/mL; p = 0.02). Monocyte function was not suppressed after exposure to MV fractions. RBC supernatants that had been depleted of MVs remained immunosuppressive. Treating RBC supernatants with heat followed by RNase (to degrade protein-bound RNA) prevented RBC supernatant-induced monocyte suppression.
CONCLUSION: Our findings implicate soluble mediators of stored RBC-induced monocyte suppression outside of MV fractions and suggest that extracellular protein-bound RNAs (such as microRNA) may play a role in transfusion-related immunomodulation.
© 2015 AABB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25819532     DOI: 10.1111/trf.13084

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

Review 1.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

2.  Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity.

Authors:  Ruqayyah J Almizraq; Philip J Norris; Heather Inglis; Somaang Menocha; Mathijs R Wirtz; Nicole Juffermans; Suchitra Pandey; Philip C Spinella; Jason P Acker; Jennifer A Muszynski
Journal:  Blood Adv       Date:  2018-09-25

3.  New blood for old? High quality evidence that fresh red blood cells confer no benefit for critically ill patients.

Authors:  Timothy S Walsh; Nicole P Juffermans
Journal:  Intensive Care Med       Date:  2018-03-14       Impact factor: 17.440

4.  Leukoreduction of packed red blood cells attenuates proinflammatory properties of storage-derived microvesicles.

Authors:  Jillian R Richter; Jeffrey M Sutton; Phillip Hexley; Taylor A Johannigman; Alex B Lentsch; Timothy A Pritts
Journal:  J Surg Res       Date:  2017-12-22       Impact factor: 2.192

5.  Contrasting effects of stored allogeneic red blood cells and their supernatants on permeability and inflammatory responses in human pulmonary endothelial cells.

Authors:  Junghyun Kim; Trang T T Nguyen; Yue Li; Chen-Ou Zhang; Boyoung Cha; Yunbo Ke; Michael A Mazzeffi; Kenichi A Tanaka; Anna A Birukova; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

6.  Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates.

Authors:  Bérangère Devalet; Adeline Wannez; Nicolas Bailly; Lutfiye Alpan; Damien Gheldof; Jonathan Douxfils; Véronique Deneys; Benoît Bihin; Bernard Chatelain; Jean-Michel Dogné; Christian Chatelain; François Mullier
Journal:  Blood Transfus       Date:  2017-03-09       Impact factor: 3.443

Review 7.  Mechanisms of red blood cell transfusion-related immunomodulation.

Authors:  Kenneth E Remy; Mark W Hall; Jill Cholette; Nicole P Juffermans; Kathleen Nicol; Allan Doctor; Neil Blumberg; Philip C Spinella; Philip J Norris; Mary K Dahmer; Jennifer A Muszynski
Journal:  Transfusion       Date:  2018-01-30       Impact factor: 3.157

8.  Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016.

Authors:  Jaroslav G Vostal; Paul W Buehler; Monique P Gelderman; Abdu I Alayash; Alan Doctor; James C Zimring; Simone A Glynn; John R Hess; Harvey Klein; Jason P Acker; Philip C Spinella; Angelo D'Alessandro; Bernhard Palsson; Thomas J Raife; Michael P Busch; Timothy J McMahon; Marcos Intaglietta; Harold M Swartz; Michael A Dubick; Sylvain Cardin; Rakesh P Patel; Charles Natanson; John W Weisel; Jennifer A Muszynski; Philip J Norris; Paul M Ness
Journal:  Transfusion       Date:  2017-12-15       Impact factor: 3.157

9.  Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method.

Authors:  Ruqayyah J Almizraq; Jelena L Holovati; Jason P Acker
Journal:  Transfus Med Hemother       Date:  2018-03-16       Impact factor: 3.747

10.  Effect of fresh frozen plasma on the in vitro activation of U937 monocytes: a potential role for the age of blood donors and their underlying cytokine profile.

Authors:  Mariana Patlán; Fausto Sánchez-Muñoz; Luis M Amezcua-Guerra; Adriana Granados; Araceli Páez; Felipe Massó; Ana M Mejía; Angeles Soster; Rafael Bojalil; Lenin Pavón; Luis A Jiménez-Zamudio; Ricardo Márquez-Velasco
Journal:  Biol Res       Date:  2017-12-21       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.